SMNR · Forms 3, 4, 5
Insider trades at Semnur Pharmaceuticals, Inc.
No open-market insider buys or sells at Semnur Pharmaceuticals, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Semnur Pharmaceuticals, Inc. (SMNR) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Semnur Pharmaceuticals, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Scilex Holding Co | 10% owner | Other | 7,034,737 | Form 4 | |||
| Annu Navani | Director | Became an insider (Form 3) | Form 3 | ||||
| Scilex Holding Co | 10% owner | Sell | 11,945,151 | $16.00 | $191.1M | Form 4 | |
| Scilex Holding Co | 10% owner | Sell | 554,849 | $16.00 | $8.9M | Form 4 | |
| Jaisim Shah | Director | Became an insider (Form 3) | Form 3 | ||||
| Stephen Hoi Ma | Officer | Became an insider (Form 3) | Form 3 | ||||
| Yue Alexander Wu | Director | Became an insider (Form 3) | Form 3 | ||||
| Dorman Followwill | Director | Became an insider (Form 3) | Form 3 | ||||
| Jay Chun | Director | Became an insider (Form 3) | Form 3 | ||||
| Scilex Holding Co | 10% owner | Became an insider (Form 3) | Form 3 | ||||
| Henry Ji | Executive Chairperson | Became an insider (Form 3) | Form 3 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.